Ignite Creation Date:
2025-12-25 @ 2:08 AM
Ignite Modification Date:
2025-12-26 @ 12:55 AM
Study NCT ID:
NCT00201760
Status:
COMPLETED
Last Update Posted:
2017-12-27
First Post:
2005-09-12
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Gemcitabine/ Trastuzumab and Gemcitabine/ Cisplatin/ Trastuzumab in Patients With Metastatic Breast Cancer
Sponsor:
Kari Kendra
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-02-25
Start Date Type:
ACTUAL
Primary Completion Date:
2009-10-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-10-31
Completion Date Type:
ACTUAL
First Submit Date:
2005-09-12
First Submit QC Date:
None
Study First Post Date:
2005-09-20
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-06-15
Results First Submit QC Date:
None
Results First Post Date:
2017-11-09
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-11-30
Last Update Post Date:
2017-12-27
Last Update Post Date Type:
ACTUAL